Somewhere on a CDMO’s floor right now, a validated line is running below plan — not because the equipment failed, but because the team responsible for standing up the maintenance system, the tech transfer package, or the CQV protocol behind it never had the bandwidth to keep pace with how fast the business grew.
White Paper
The 5 CDMO Execution Gaps (and How to Close Them)
Related Resources
All Resources
post
Navigating the Evolution from ICH Q2(R1) to ICH Q2(R2) and Implementation of ICH Q14 in Biopharmaceutical Method Validation
Read More
post
Regulatory Affairs Compliance Strategies
Read More
post
The Importance of Quality in Drug Development with Insights from the FDA Fiscal Year 2023 Report on the State of Pharmaceutical Quality
Read More
post
Why are Biologics Drugs Different
Read More
Let's move from science to success.
Let’s Talk